← FDA Drug Approvals (Drugs@FDA)
ETHACRYNATE SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STERIMAX · Approved 2020-06-09
Drug application
- FDA Application #
ANDA208663- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ETHACRYNATE SODIUM
- Generic name
- ETHACRYNATE SODIUM
- Active ingredients
- ETHACRYNATE SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- STERIMAX
- Manufacturer
- Leading Pharma, LLC
- First approval
- 2020-06-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown